Impact of CYP3A4*1B and CYP3A5*3 polymorphisms on the pharmacokinetics of cyclosporine and sirolimus in renal transplant recipients

Related articles

25 Feb 2019 : Original article

Effect of Multidrug-Resistant 1 (MDR1) and CYP3A4*1B Polymorphisms on Cyclosporine-Based Immunosuppressive Therapy in Renal Transplant Patients

Maciej J. Kotowski, Anna Bogacz, [...] Joanna Bartkowiak-Wieczorek, Karol Tejchman, Krzysztof Dziewanowski, Marek Ostrowski, Bogusław Czerny, Edmund Grześkowiak, Bogusław Machaliński, Jerzy Sieńko - Show fewer authors

DOI: 10.12659/AOT.914683

29 Jun 2012

Association of transforming growth factor β1 (TGF- β1) with gingival hyperplasia in heart transplant patients undergoing cyclosporine-A treatment

Katarzyna Pakosz, Michał Zakliczyński, [...] Wojciech Król, Łukasz Pyka, Helena Zakliczyńska, Dominika Trybunia, Rafał Wiench, Leszek Ilewicz, Bronisława Skrzep-Poloczek, Roman Przybylski, Marian Zembala - Show fewer authors

DOI: 10.12659/AOT.883222

22 Dec 2017 : Case report

Lymphedema of the Transplanted Kidney and Abdominal Wall with Ipsilateral Pleural Effusion Following Kidney Biopsy in a Patient Treated with Sirolimus: A Case Report and Review of the Literature

Farin Rashid-Farokhi, Haleh Afshar

DOI: 10.12659/AJCR.905962

30 Dec 2017 : Clinical Research

Analysis of CYP2C19 Genetic Polymorphism in a Large Ethnic Hakka Population in Southern China

Zhixiong Zhong, Jingyuan Hou, [...] Bing Li, Qifeng Zhang, Sudong Liu, Cunren Li, Zhidong Liu, Min Yang, Wei Zhong, Pingsen Zhao - Show fewer authors

DOI: 10.12659/MSM.905337

12 Sep 2015 : Original article

A Retrospective Comparison of Mycophenolate Mofetil with Low-Exposure Cyclosporine Versus Standard Cyclosporine Therapy in De Novo Liver Transplant Patients

Jonas D. Senft, Daniel N. Gotthardt, [...] Lina Frischbier, Helge Bruns, Peter Schemmer - Show fewer authors

DOI: 10.12659/AOT.894078

20 Nov 2014 : Original article

Cardiovascular Risk Factors after Conversion from Cyclosporine to Tacrolimus in Children after Liver Transplantation

Piotr Czubkowski, Aldona Wierzbicka, [...] Piotr Socha, Irena Jankowska, Joanna Pawłowska - Show fewer authors

DOI: 10.12659/AOT.890865

21 Feb 2009

Cyclosporine A, but not tacrolimus, is associated with impaired proliferation and differentiation of human osteoblast-like cells in vitro

Rodrigo Oliveira Moreira, Leandro Souza Thiago, [...] Felipe Leite Oliveira, Alex Balduino, Radovan Borojevic, Maria Eugenia Leite Duarte, Maria Lucia Fleiuss Farias - Show fewer authors

13 Feb 2018 : Original article

Cyclosporin A Aggravates Calcification of Vascular Smooth Muscle Cells Under High-Glucose Conditions with a Calcifying Medium

Dae Hee Kim, Keon Cheol Lee, [...] Sang Youb Han - Show fewer authors

DOI: 10.12659/AOT.908168

31 Mar 2012

Conversion from everolimus with low-exposure cyclosporine to everolimus with mycophenolate sodium maintenance therapy in kidney transplant recipients: A randomized, open-label multicenter study

Laetitia Albano, Eric Alamartine, [...] Olivier Toupance, Bruno Moulin, Pierre Merville, Jean Philippe Rerolle, Rachel Tetaz, Marie-Christine Moal, Nassim Kamar, Christophe Legendre, Stéphane Quéré, Fabienne Di Giambattista, Arara Terpereau, Jacques Dantal - Show fewer authors

DOI: 10.12659/AOT.882637

30 Sep 2011

Ezetimibe in sirolimus-associated hyperlipidemia: To add or not to add to statins?

Mariusz Niemczyk, Leszek Paczek

18 Apr 2018 : Laboratory Research

Pharmacokinetic and Pharmacodynamics of Self-Assembled Cubic Liquid Crystalline Nanoparticle Gel After Transdermal Administration

Na Zhu, Xiao-xiang Wu, [...] Yong Tian, Jin-xiu Zhu, Jian-chun Li - Show fewer authors

DOI: 10.12659/MSM.906140

11 Jun 2016 : Animal Research

Effect of Immunosuppressive Therapy on Proteinogram in Rats

Karolina Kędzierska, Krzysztof Sindrewicz, [...] Katarzyna Sporniak-Tutak, Joanna Bober, Małgorzata Stańczyk-Dunaj, Barbara Dołęgowska, Robert Kaliszczak, Jerzy Sieńko, Joanna Kabat-Koperska, Edyta Gołembiewska, Kazimierz Ciechanowski - Show fewer authors

DOI: 10.12659/MSM.895856

30 Jun 2011

Generic formulation of Cyclosporine A, Equoral®, in de novo kidney transplant recipients: Five-year follow-up

Mariusz Niemczyk, Leszek Paczek

11 Oct 2013 : Original article

Differential expression of heat shock proteins in healthy and diseased human renal allografts

Stephen O'Neill, Timothy G. Ingman, [...] Stephen J. Wigmore, Ewen M. Harrison, Christopher O. Bellamy - Show fewer authors

DOI: 10.12659/AOT.889599

26 Sep 2012

Influence of conversion from cyclosporine A to tacrolimus on insulin sensitivity assessed by euglicaemic hyperinsulinemic clamp technique in patients after kidney transplantation

Maciej Bułanowski, Jerzy Chudek, [...] Andrzej Więcek - Show fewer authors

DOI: 10.12659/AOT.883459

17 Jun 2008

Human Leukocyte Antigen (HLA) B-27 and older age are associated with augmented cyclosporine blood bioavailability in renal allograft recipients: An attempt toward individualization of immunosuppression

Eghlim Nemati, Saeed Taheri, [...] Vahid Pourfarziani, Behzad Einollahi - Show fewer authors

17 Jun 2008

Sirolimus induced dyslipidemia in tacrolimus based vs. tacrolimus free immunosuppressive regimens in renal transplant recipients

Hakeam A. Hakeam, Ahmed H. Al-Jedai, [...] Syed M. Raza, Khalid Hamawi - Show fewer authors

16 Jun 2006

Conversion From Cyclosporine-Based Immunosuppression to Tacrolimus/ Mycophenolate Mofetil in Patients with Refractory and Ongoing Acute Renal Allograft Rejection

Maria Boratynska, Miroslaw Banasik, [...] Dariusz Patrzalek, Marian Klinger - Show fewer authors

15 Dec 2002

Risk Factors of Gingival Overgrowth in Kidney Transplant Recipients Treated with Cyclosporine

M Radwan-Oczko, M Boratyńska, [...] M Klinger, M Ziętek - Show fewer authors